The short answer
Deciding whether to accept more anticancer treatment is a comparison of benefit against burden. Performance status, the diminishing return of each successive line, and time cost are the practical inputs.
Each successive line of treatment for advanced cancer generally produces smaller response rates and shorter durations of benefit than the one before it.
Performance status, meaning how much of the day you are up and functioning, is the most useful single predictor of whether treatment will help or harm you.
A response on a scan means the tumor shrank; it does not automatically mean you will live longer or feel better, and those are separate questions worth asking separately.
Time toxicity, the days consumed by appointments, travel, scans and hospital stays, is a real cost that is rarely quantified for patients.
Choose how you want to understand this
The full explanation.
The question underneath the question
"Is it worth it" is not a question about cancer. It is a comparison. What is a treatment likely to give you, and what is it likely to take? The comparison needs numbers on both sides. Most people are handed the first half and left to guess the second.
Benefit shrinks with each line
In advanced cancer, treatments are given in sequence. When one stops holding the disease, another is offered. As a general pattern, each new line produces a smaller share of patients who respond. And the responses last less time. This is not universal. Targeted therapies and immunotherapies have changed the shape of it in some cancers. But it is the background to any offer. A fourth-line offer should be read differently from a first-line one. It is fair to ask directly how this one compares with what the last regimen gave you.
Performance status is the number that matters most
Oncologists rate how much of the day you spend up and functioning. They usually use the ECOG scale, which runs from 0 to 4. It sounds crude. It predicts more than most laboratory values do. Most clinical trials require ECOG 0 to 2. Once someone is spending more than half the day in bed, chemotherapy becomes steadily more likely to cause harm than benefit. Has your performance status dropped noticeably over the last two or three months? That trend is one of the most important pieces of information you have. Ask the team to state it plainly.
What a scan result does and does not tell you
A response means the tumor got smaller. That is not the same as living longer. It is not the same as feeling better either. A treatment can shrink a lesion and still make the months it buys unpleasant. Another can fail to shrink anything and still relieve a symptom. So ask which of the three this treatment is expected to deliver. And ask for the survival benefit as a median difference in months, not as a percentage. Percentages sound larger than they are.
Time toxicity
Count the days. Infusion days. The day after, when you are flattened. Travel, blood draws, scans, clinic waits. And the unplanned admissions that treatment makes more likely. For some regimens this adds up to a week a month. When remaining time is measured in months, a week a month is a large slice of it. Nobody puts that on the consent form. Ask the team to estimate it. Then set it against what you would otherwise do with those days.
Treatment in the last weeks
Studies of end-of-life cancer care keep finding the same thing. Significant numbers of patients start a new chemotherapy regimen within 30 days of death. And chemotherapy in the final week goes with worse quality of life. This is not an argument against treatment. It is an argument for knowing where you are on the curve. And for agreeing in advance what would tell you it is time to stop.
Palliative care is not the alternative to treatment
Specialist palliative care can run alongside anticancer treatment. It can start as soon as advanced disease is diagnosed. A randomised trial enrolled 151 patients with metastatic non-small-cell lung cancer. Some received early palliative care alongside standard oncology care. They reported better quality of life and fewer depressive symptoms. They received less aggressive care at the end of life. And they lived longer on average: 11.6 months against 8.9. Accepting palliative care does not mean declining treatment. Declining it does not gain you anything.
Deciding without deciding forever
Most of these choices do not have to be settled once and for all. There is a structure called a time-limited trial of therapy. You agree to start. You agree in advance on the scan or the functional marker that will judge it. And you agree what happens if it is not working. That lets you try something without committing to trying everything. It also puts the stopping decision on a calendar, rather than on a bad day.
Sources
Words to know
Tap any term to see what it means.
Common questions
What should I ask before agreeing to the next line of treatment?
Four things. What is the chance this shrinks or holds the cancer, as a number. If it works, for roughly how long. What it will do to how I feel and what I can do, week by week. And what the goal is: cure, more time, or symptom control. If the answer to the last is symptom control, ask whether there is a way to control the symptom without the drug.
What is performance status and why does everyone keep mentioning it?
It is a rating of how much of the day you can be up and active, usually the ECOG scale from 0 to 4. Most clinical trials require ECOG 0 to 2. At ECOG 3 or 4, meaning more than half the day in bed or chair-bound, most anticancer treatment becomes more likely to cause harm than benefit. It is used because it predicts outcomes better than the cancer type alone.
Is a clinical trial a reasonable option at this point?
It can be, and eligibility usually depends on performance status and organ function, which is a reason to ask early rather than after a further decline. Understand the phase: phase 1 trials are designed primarily to establish safe dosing, and the chance of personal benefit, while not zero, is lower than people commonly assume. Ask what the trial requires in visits and biopsies.
If I decline treatment now, can I change my mind later?
In most cases yes, though eligibility for some options, especially trials, depends on being well enough at the time. Ask what would still be available in a month or in three months, and what would close off. That answer often clarifies the decision more than the survival numbers do.
Does more treatment mean more time?
Sometimes, and by margins often smaller than the way they are described suggests. Ask for the median difference in months rather than percentages, and ask what the range looks like. Then set that against what the treatment costs you in days spent unwell and days spent in a building.
Questions to ask your doctor
Being prepared helps you get the most out of your appointments. Save or print these questions.
Tap a question to save it to your list (kept on this device).
Speak With Trained Specialists & Human Navigators
Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.
Talk to a trained cancer information specialist
Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.
Contact your oncology team
Locate after-hours contact numbers, portal messages, or urgent triage phone lines.
Find a patient navigator
Get one-on-one help with appointments, logistics, translation, and care coordination.
Find a genetic counselor
Discuss inherited mutation risk, family history, and genetic testing options.
Find an oncology social worker
Access emotional counseling, family support groups, and mental health resources.
Find a financial navigator
Locate copay assistance foundations, grant programs, and lodging/travel support.
Find a clinical-trial specialist
Search matching studies and speak with NCI trial information specialists.
Get urgent help
Immediate emergency guidance for fever (>100.4°F during chemo), severe pain, or shortness of breath.
Help Us Improve This Guide
Did this explanation answer your question and help you determine your next step?
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Where to get help with this, by name
A hospital social worker or financial navigator is the best first call if you have one. If you do not, these organisations help at no cost to you.
- Patient Advocate Foundation — (800) 532-5274. Case managers take on insurance appeals, denials and medical debt with you. Free.
- TotalAssist (Patient Advocate Foundation's copay programme, merged with the PAN Foundation in 2026) — 866-512-3861. Help with medication copays, coinsurance and deductibles, insurance premiums, and office-visit and administration charges on the day of treatment, across nearly 150 conditions.
- CancerCare — 800-813-HOPE (4673). Oncology social workers, free counselling and support groups. Limited financial help with transport, home care, child care and lodging for people in active treatment who meet their income guidelines — funding is first-come, first-served, so call to ask what is open.
- Triage Cancer — 424-258-4628. Free legal and financial navigation: insurance, employment rights, disability.
- Blood Cancer United (formerly the Leukemia & Lymphoma Society) — (800) 955-4572. Information Specialists answer questions on treatment, insurance and financial problems.
- HealthCare.gov — 1-800-318-2596. For questions about the external review process — the independent review your insurer is required by law to accept.
Your state Department of Insurance regulates insurers and takes consumer complaints. On Medicare, your State Health Insurance Assistance Program (SHIP) gives free one-to-one counselling. If a specific drug is the problem, ask the manufacturer about its patient assistance programme.
Phone numbers checked 31 July 2026. Programmes and eligibility change — if a number has moved, please tell us.
Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.
Written by: Cancer ExplainedSources last checked: 2026-07-30 what this meansLast updated: 2026-08-10Next planned review: 2028-07-30
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status — Source checked. This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.
General education — varies by person. Answers genuinely differ between people. This page explains what commonly varies and points you to your care team for your situation.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status: Source checked — This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
Read more about our editorial process, our use of AI, and our corrections policy.
Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.
After using this page, do you understand what to do next?
Anonymous — we only record the answer, never who gave it.
Related articles
Still have questions?
Educational answers, plain language
Free to print and share